NASDAQ:SCPS

Scopus Biopharma Stock Insider Trading

etoro logo Buy SCPS
*Your capital is at risk
$0.0004
+0 (+0%)
At Close: Jun 22, 2026

Scopus BioPharma Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 5.36M and sold 12M SCPS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
0
Buy 5.36M shares
Sell 12M shares
94% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Aug 19, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 2 000
Value: $8K
Aug 18, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 1 000
Value: $4K
Aug 18, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 1 000
Value: $4K
Aug 17, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 1 000
Value: $4K
Aug 17, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 1 000
Value: $4K
Jul 31, 2021
Buy
W Warrants
J-Other
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 1 068 016
Value: $4.27M
Jul 31, 2021
Buy
W Warrants
J-Other
Lamstein Joshua R
Chairman
CEO / President 1 068 016
Value: $4.27M
Jul 31, 2021
Buy
W Warrants
J-Other
Lamstein Joshua R
Chairman
CEO / President 16 963
Value: $67.9K
Jul 31, 2021
Buy
Convertible Notes
J-Other
Lamstein Joshua R
Chairman
CEO / President 0
Value: $0
Jul 31, 2021
Sell
Convertible Notes
C-Conversion
Lamstein Joshua R
Chairman
CEO / President 0
Value: $0
Jul 31, 2021
Buy
W Warrants
J-Other
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 1 068 016
Value: $4.27M
Jul 31, 2021
Buy
W Warrants
J-Other
Lamstein Joshua R
Chairman
CEO / President 1 068 016
Value: $4.27M
Jul 31, 2021
Buy
W Warrants
J-Other
Lamstein Joshua R
Chairman
CEO / President 16 963
Value: $67.9K
Jul 31, 2021
Buy
Convertible Notes
J-Other
Lamstein Joshua R
Chairman
CEO / President 0
Value: $0
Jul 31, 2021
Sell
Convertible Notes
C-Conversion
Lamstein Joshua R
Chairman
CEO / President 0
Value: $0
Jul 27, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 200
Value: $908
Jul 27, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 200
Value: $908
Jul 26, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 400
Value: $2K
Jul 26, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 1 000
Value: $5K
Jul 26, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 400
Value: $2K
Jul 26, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 1 000
Value: $5K
Jul 23, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 1 100
Value: $5K
Jul 23, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Lamstein Joshua R
Chairman
CEO / President 1 500
Value: $7K
Jul 23, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 1 100
Value: $5K
Jul 23, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Lamstein Joshua R
Chairman
CEO / President 1 500
Value: $7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT SCOPUS BIOPHARMA INC.
Scopus BioPharma
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) inhibitors; and MRI-1867, rationally designed, orally available, dual-action, hybrid, and small molecule...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE